Sensydia: Sensydia Secures $3M to Advance AI-Based Cardiac Assessment Platform
Company's technology aims to enable earlier detection and therapeutic guidance for patients with heart failure and pulmonary hypertension.
Read full article »
Sensydia develops a cardio-respiratory monitor that measures heart functions of patients.
Read more